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Sir,
Glycosylated hemoglobin (HbA1C) level is a commonly
used laboratory investigation in diabetes patients, which
reflects glycemic control over a period of 3 months. In
various instances, HbA1C levels may be falsely low
leading to suboptimal management of diabetes. One
such example is the use of dapsone, which is an
antibiotic, commonly used to treat various conditions
such as leprosy, acne, ulcers etc.
We report a 48-year old female patient with type 2
diabetes and hypertension who was started on dapsone
for non-healing oral ulcers. She was on biphasic insulin
aspart 30 (novomix 30) before meals for her diabetes.
Before the start of dapsone, she had an HbA1C of
10.7%; therefore, her insulin doses were increased and
metformin was also added. After the start of dapsone,
the patient started having falsely low HbA1C of <4% with
fasting blood glucose value of 105 - 110 mg/dl and a
random blood glucose value of 210 mg/dl with no
hypoglycemic episodes. She did did not have anemia
before the start of dapsone (hemoglobin (Hb) 12 gm/dl);
however, 5 months after the start of dapsone therapy,
she developed mild anemia (Hb, 9.6 gm/dl) with a very
low HbA1C of <4%. Dapsone was stopped after one
year of her treatment with resolution of oral ulcers and
after 3 months, her HbA1C increased to 6.6% and 6
months later, it became 8.8%.
The relation of dapsone usage and falsely low HbA1c
has been established by several case reports.1-3 Several
mechanisms have been proposed to explain this
phenomenon. Firstly, dapsone causes a decrease in the
average life span of red blood cells (RBC's) thus
decreasing HbA1C levels.2 Furthermore, dapsone may
also cause the conversion of hemoglobin to methemo-
globin which causes spurious HbA1C levels.3 In this
patient, mild anemia developed after the start of
dapsone which might have contributed to the low HbA1C
levels. Physicians should be aware of dapsone-induced
lowering of HbA1C. Perhaps in patients receiving
dapsone, fasting and random blood sugars should be
used to guide the management of diabetes in order to
avoid any confusion.
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